|
Aptilon and Skura announce collaboration to enhance multi-channel effectiveness of bio-pharmaceutical sales forces
- Agreement combines powers of Tablet PC with Internet-based AxcelRxsm Live video detailing and self-directed learning -
Montreal, Quebec and Mississauga, Ontario May 13th, 2008 – Aptilon Corporation (TSX-V: APZ), a leading provider of physician access through its innovative alternative sales and marketing channel, and Skura Corporation, a leader in next generation software for Closed-Loop Marketing (CLM), today announced that they have joined forces to offer bio-pharmaceutical sales organizations a streamlined approach to creating the “Sales Force of the Future.”
Through this new collaboration, the two companies will offer bio-pharmaceutical companies the ability to integrate Skura’s technology-enabled, in-office sales calls with Aptilon’s AxcelRx Live and self-directed internet-based channel. The partnership enables thousands of sales representatives in the field who use Tablet PCs to engage physicians effectively live online and to selectively showcase self-directed assets as a way to extend the multi-channel education process through AxcelRx.
Aptilon and Skura have combined forces to deliver Designer™ Plus, the first-ever promotional content authoring tool with the ability to publish multimedia content for PCs, the Web and AxcelRx Live channels. The joint adoption of an “open standards” approach to multi-channel promotion will help marketers avoid proprietary systems that limit flexibility and increase costs for content development and revisions. In addition, content viewed by or presented to health care professionals can be tracked to allow for real-time promotional ROI measurement across all touch points.
“This new partnership with Aptilon, the leader in alternative sales channel education, expands our offering to pharmaceutical companies,” said Chris Skura, Founder and CEO of Skura Corporation. “Through this collaboration, we will provide value to marketers that is unparalleled among manufacturers of CLM systems.”
“Over the past year we’ve helped several companies build the ‘Sales Force of the Future,’ and our affiliation with Skura further cements our leadership position in multi-channel sales,” said Mark Benthin, COO of Aptilon. “Partnering with a leader among Closed-Loop Marketing is the logical next step in our growth, expanding the number of representatives using our tools and increasing the number of online interactions with physicians.”
Skura is a leader in enhancing representatives’ face-to-face interactions with physicians using state-of-the art eDetail presentations on a Tablet PC. These presentations are a key component of CLM, a strategic business approach that “closes the loop” between marketing, sales and physicians. CLM measures the results of marketing and sales campaigns by tracking and acting on the responses of targeted physicians.
Aptilon’s AxcelRx Live increases bio-pharmaceutical companies’ access to key physicians in the U.S., allowing sales representatives to provide live education to physicians at a time and place convenient for them, typically in their homes during nights and weekends. Aptilon links physicians to live or virtual bio-pharma-sponsored programs through its ReachNetSM physician access channel, an extensive network of partner and company-owned websites, with access to more than 450,000 physicians. AxcelRx Live delivers an average of eight- to 15-minute representative-physician interactions.
About Skura
Founded in 1996, Skura has grown into an international company with satisfied customers in 22 countries. Life Science manufacturers have benefited from Skura's unique value proposition as a provider of full CRM consulting services and market leading innovative software solutions for Closed-Loop Marketing (CLM) and Tablet PC detailing.
Skura Corporation is recognized for its expertise in helping Life Science customers maximize their investments in Customer Relationship Management (CRM) technology by enhancing the investments already made. Using best-in-class applications from Verticals onDemand, Oracle, Siebel, Siperian, Microsoft, and SFX, Skura has been delivering quality solutions that increase sales, marketing, and medical effectiveness and efficiency for a decade.
As a recognized leader of software solutions and services, Skura continues to earn an envied reputation in process design, as well as technical development and support of Oracle technologies. For more information, visit www.skura.com.
Designer™ is a trademark of Skura Corporation.
About Aptilon
Aptilon enables pharmaceutical, biotech and medical device companies to effectively reach and interact with physicians via the Internet through its innovative AxcelRx Live video detailing (with company reps), virtual programs, peer selling and other sales and marketing programs. Leading health care companies have adopted Aptilon’s ReachNet physician access channel, driving tens of thousands of high-quality rep-physician interactions averaging eight to 10 minutes in length for primary care physicians and up to 15 minutes for specialists. Aptilon provides the infrastructure necessary for sales representatives to build physician awareness, understanding and preference during all stages of a product’s life cycle, from pre-launch education through end stage support. For more information, visit www.aptilon.com.
AxcelRxSM and ReachNetSM are service marks of Aptilon Corporation.
Forward-looking statements
This news release contains forward-looking information. These statements relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management of Aptilon. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Aptilon does not assume any obligation to update or revise them to reflect new events or circumstances.
###
The TSX Venture Exchange Inc. has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
|